RISK OF SARS-COV-2 INFECTION FOLLOWING THREE DOSES OF BNT162B2 OR MRNA-1273 IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES

被引：1

作者：

Raptis, C. E. ^{[1
]}

Polysopoulos, C. ^{[1
]}

Berger, C. ^{[2
,3
]}

Ciurea, A. ^{[4
]}

Andrey, D. O. ^{[5
,6
]}

Lescuyer, P. ^{[5
]}

Maletic, T. ^{[1
]}

Riek, M. ^{[1
]}

Scherer, A. ^{[1
]}

Von Loga, I.

Safford, J. ^{[7
]}

Lauper, K. ^{[6
,8
]}

Moeller, B. ^{[9
]}

Vuilleumier, N. ^{[6
,8
]}

Finckh, A.

Rubbert-Roth, A. ^{[10
]}

机构：

[1] SCQM Fdn, Stat Grp, Zurich, Switzerland

[2] Univ Hosp Basel, Univ Ctr Immunol & Immunizat Clin, Basel, Switzerland

[3] Univ Basel, Dept Biomed, Translat Immunol, Basel, Switzerland

[4] Univ Zurich, Zurich Univ Hosp, Dept Rheumatol, Zurich, Switzerland

[5] Geneva Univ Hosp, Div Lab Med, Geneva, Switzerland

[6] Univ Geneva, Fac Med, Geneva, Switzerland

[7] RheumaCura Fdn, Bern, Switzerland

[8] Geneva Univ Hosp, Div Rheumatol, Geneva, Switzerland

[9] Bern Univ Hosp, Div Rheumatol & Immunol, Inselspital, Bern, Switzerland

[10] St Gallen Cantonal Hosp, Div Rheumatol & Immunol, St Gallen, Switzerland

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷

关键词：

COVID; Inflammatory arthritides; Vaccination/immunization;

D O I：

10.1136/annrheumdis-2023-eular.5483

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

POS0547

引用

页码：539 / 539

页数：1

共 1 条

[1] Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseases [J].

Raptis, Catherine E. ;

Berger, Christoph T. ;

Ciurea, Adrian ;

Andrey, Diego O. ;

Polysopoulos, Christos ;

Lescuyer, Pierre ;

Maletic, Tanja ;

Riek, Myriam ;

Scherer, Almut ;

von Loga, Isabell ;

Safford, Judith ;

Lauper, Kim ;

Moller, Burkhard ;

Vuilleumier, Nicolas ;

Finckh, Axel ;

Rubbert-Roth, Andrea .

FRONTIERS IN IMMUNOLOGY, 2022, 13

← 1 →